FDA Schedules GDUFA Public Meeting For June 15

FDA will hold a public meeting June 15 on the upcoming reauthorization of the Generic Drug User Fee Act, a step required to kick off talks this summer between the agency and industry on the next iteration of GDUFA. The current version of GDUFA expires at the end of September 2017. The agency says the public meeting will include presentations by FDA staff, scientific and academic experts, health care experts, representatives of patient and consumer groups, the generic drug industry...